{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T23:15:11Z","timestamp":1775603711266,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,9,20]],"date-time":"2013-09-20T00:00:00Z","timestamp":1379635200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1007\/s00702-013-1074-1","type":"journal-article","created":{"date-parts":[[2013,9,19]],"date-time":"2013-09-19T10:28:07Z","timestamp":1379586487000},"page":"21-26","source":"Crossref","is-referenced-by-count":24,"title":["Onabotulinumtoxin type A (Botox\u00ae) versus Incobotulinumtoxin type A (Xeomin\u00ae) in the treatment of focal idiopathic palmar hyperhidrosis: results of a comparative double-blind clinical trial"],"prefix":"10.1007","volume":"121","author":[{"given":"A.","family":"Campanati","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Giuliodori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Martina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Giuliano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Ganzetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Offidani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,9,20]]},"reference":[{"key":"1074_CR1","doi-asserted-by":"crossref","first-page":"S208","DOI":"10.1002\/(SICI)1097-4598(1997)6+<208::AID-MUS15>3.0.CO;2-1","volume":"6","author":"MF Brin","year":"1997","unstructured":"Brin MF (1997) Dosing, administration, and a treatment algorithm for use of botulinum toxin A for adult-onset spasticity. Spasticity Study Group. Muscle Nerve Suppl. 6:S208\u2013S220","journal-title":"Muscle Nerve Suppl."},{"issue":"3","key":"1074_CR2","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jaad.2003.09.006","volume":"51","author":"A Campanati","year":"2004","unstructured":"Campanati A, Lagalla G, Penna L, Gesuita R, Offidani A (2004) Local neural block at the wrist for treatment of palmar hyperhidrosis with botulinum toxin: technical improvements. J Am Acad Dermatol 51(3):345\u2013348","journal-title":"J Am Acad Dermatol"},{"key":"1074_CR3","first-page":"52","volume":"17","author":"A Campanati","year":"2007","unstructured":"Campanati A, Bernardini ML, Gesuita R, Offidani A (2007) Plantar focal idiopathic hyperhidrosis and botulinum toxin: a pilot study. Eur J Dermatol 17:52\u201354","journal-title":"Eur J Dermatol"},{"issue":"8","key":"1074_CR4","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/j.1468-3083.2010.03880.x","volume":"25","author":"A Campanati","year":"2011","unstructured":"Campanati A, Sandroni L, Gesuita R, Giuliano A, Giuliodori K, Marconi B, Ganzetti G, Offidani A (2011) Treatment of focal idiopathic hyperhidrosis with Botulinum Toxin Type A: clinical predictive factors of relapse-free survival. J Eur Acad Dermatol Venereol 25(8):917\u2013921","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"1074_CR5","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/mus.21343","volume":"40","author":"L Carli","year":"2009","unstructured":"Carli L, Montecucco C, Rossetto O (2009) Assay of diffusion of different botulinum neurotoxin type a formulations injected in the mouse leg. Muscle Nerve 40(3):374\u2013380","journal-title":"Muscle Nerve"},{"key":"1074_CR6","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1046\/j.1524-4725.2000.00851.x","volume":"26","author":"A Carruthers","year":"2000","unstructured":"Carruthers A, Carruthers J (2000) Toxins 99, new information about the botulinum neurotoxins. Dermatol Surg 26:174\u2013176","journal-title":"Dermatol Surg"},{"issue":"3","key":"1074_CR7","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00702-010-0372-0","volume":"117","author":"D Dressler","year":"2010","unstructured":"Dressler D (2010) Comparing Botox and Xeomin for axillar hyperhidrosis. J Neural Transm. 117(3):317\u2013319","journal-title":"J Neural Transm."},{"issue":"3","key":"1074_CR8","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1468-1331.2011.03559.x","volume":"19","author":"D Dressler","year":"2012","unstructured":"Dressler D (2012) Five-year experience with incobotulinumtoxin A (Xeomin\u00ae): the first botulinum toxin drug free of complexing proteins. Eur J Neurol 19(3):385\u2013389","journal-title":"Eur J Neurol"},{"key":"1074_CR9","first-page":"17","volume":"2","author":"F Durif","year":"1995","unstructured":"Durif F (1995) Clinical bioequivalence of the current commercial preparations of botulinum toxin. Eur J Neurol 2:17\u201318","journal-title":"Eur J Neurol"},{"key":"1074_CR10","doi-asserted-by":"crossref","unstructured":"Evidente VG, Fernandez HH, Ledoux MS, Brashear A, Grafe S, Hanschmann A, Comella CL (2013) A randomized, double-blind study of repeated incobotulinumtoxin A (Xeomin\u00ae) in cervical dystonia. J Neural Transm [Epub ahead of print]","DOI":"10.1007\/s00702-013-1048-3"},{"issue":"Suppl 2","key":"1074_CR11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1468-1331.2009.02879.x","volume":"16","author":"J Frevert","year":"2009","unstructured":"Frevert J (2009a) Xeomin: an innovative new botulinum toxin type A. Eur J Neurol 16(Suppl 2):11\u201313","journal-title":"Eur J Neurol"},{"issue":"5","key":"1074_CR12","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.toxicon.2009.03.010","volume":"54","author":"J Frevert","year":"2009","unstructured":"Frevert J (2009b) Xeomin\u00ae is free from complexing proteins. Toxicon 54(5):697\u2013701","journal-title":"Toxicon"},{"issue":"Suppl 5","key":"1074_CR13","first-page":"5","volume":"79","author":"DA Glaser","year":"2007","unstructured":"Glaser DA, Hebert AA, Pariser DM, Solish N (2007) Primary focal\u00a0hyperhidrosis: scope of the problem. Cutis 79(Suppl 5):5\u201317 (Review)","journal-title":"Cutis"},{"key":"1074_CR14","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1503\/cmaj.1040708","volume":"172","author":"A Haider","year":"2005","unstructured":"Haider A, Solish N (2005) Focal hyperhidrosis: diagnosis and management. CMAJ 172:69\u201375","journal-title":"CMAJ"},{"issue":"5","key":"1074_CR15","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2519\/jospt.1992.16.5.215","volume":"16","author":"GF Hamilton","year":"1992","unstructured":"Hamilton GF, McDonald C, Chenier TC (1992) Measurement of grip strength: validity and reliability of the sphygmomanometer and jamar grip dynamometer. J Orthop Sports Phys Ther 16(5):215\u2013219","journal-title":"J Orthop Sports Phys Ther"},{"key":"1074_CR16","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1159\/000092285","volume":"212","author":"H Hamm","year":"2006","unstructured":"Hamm H, Naumann MK, Kowalski JW, K\u00fctt S, Kozma C, Teale C (2006) Primary focal hyperhidrosis: disease characteristics and functional impairment. Dermatology 212:343\u2013353","journal-title":"Dermatology"},{"issue":"1","key":"1074_CR17","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1524-4725.2009.01364.x","volume":"36","author":"D Hexsel","year":"2010","unstructured":"Hexsel D, Rodrigues TC, Soirefmann M, Zechmeister-Prado D (2010) Recommendations for\u00a0performing\u00a0and\u00a0evaluating\u00a0the\u00a0results\u00a0of the minor test according to a sweating intensity visual scale. Dermatol Surg 36(1):120\u2013122","journal-title":"Dermatol Surg"},{"key":"1074_CR18","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jaad.2003.12.029","volume":"51","author":"J Hornberger","year":"2004","unstructured":"Hornberger J, Grimes K, Naumann M et al (2004) Recognition, diagnosis, and treatment of primary focal hyperhidrosis. J Am Acad Dermatol 51:274\u2013286","journal-title":"J Am Acad Dermatol"},{"key":"1074_CR19","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s10286-008-0506-8","volume":"19","author":"BM Illigens","year":"2009","unstructured":"Illigens BM, Gibbons CH (2009) Sweat testing to evaluate autonomic function. Clin Auton Res 19:79\u201387","journal-title":"Clin Auton Res"},{"key":"1074_CR20","first-page":"725","volume":"5","author":"J Park","year":"2011","unstructured":"Park J, Lee MS, Harrison AR (2011) Profile of Xeomin\u00ae (incobotulinumtoxin A) for the treatment of blepharospasm. Clin Ophthalmol 5:725\u2013732","journal-title":"Clin Ophthalmol"},{"key":"1074_CR21","doi-asserted-by":"crossref","unstructured":"Lear W, Kessler E, Solish N, Glaser DA (2007) An epidemiological study of hyperhidrosis. Dermatol Surg 33(1 Spec No.) S69\u2013S75","DOI":"10.1111\/j.1524-4725.2006.32334.x"},{"key":"1074_CR22","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1046\/j.1524-4725.2002.02039.x","volume":"28","author":"NJ Lowe","year":"2002","unstructured":"Lowe NJ, Yamauchi PS, Lask GP, Patnaik R, Iyer S (2002) Efficacy and safety of botulinum toxin type A in the treatment of palmar hyperhidrosis: a double-blind, randomized, placebo-controlled study. Dermatol Surg 28:822\u2013827","journal-title":"Dermatol Surg"},{"key":"1074_CR23","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1111\/j.1468-1331.2007.01683.x","volume":"14","author":"A Pickett","year":"2007","unstructured":"Pickett A, O\u2019Keeffe R, Panjwani N (2007) The protein load of therapeutic botulinum toxins. Eur J Neurol 14:e11","journal-title":"Eur J Neurol"},{"key":"1074_CR24","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/mds.870120627","volume":"12","author":"C Sampaio","year":"1997","unstructured":"Sampaio C, Ferreira JJ, Simoes F, Rosas MJ, Magalhaes M, Correia AP et al (1997) DYSBOT: a single-blind, randomized parallel study to determine whether any differences can be detected in the efficacy and tolerability of two formulations of botulinum toxin type A\u2014Dysport and Botox\u2014assuming a ratio of 4:1. Mov Disord 12:1013\u20131018","journal-title":"Mov Disord"},{"key":"1074_CR25","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0190-9622(89)70081-5","volume":"1","author":"K Sato","year":"1989","unstructured":"Sato K, Kang WH, Saga K, Sato KT (1989) Biology of sweat glands and their disorders. II. Disorders of sweat gland function. J Am Acad Dermatol 1:713\u2013726","journal-title":"J Am Acad Dermatol"},{"key":"1074_CR26","unstructured":"Skroza N, Bernardini N, La Torre G, La Viola G, Potenza C (2011) Correlation between dermatology life quality index and minor test and differences in their levels over time in patients with axillary hyperhidrosis treated with botulinum toxin type A. Acta Dermatoverereol Croat 19:16\u201319"},{"key":"1074_CR27","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1111\/j.1524-4725.2007.33192.x","volume":"33","author":"N Solish","year":"2007","unstructured":"Solish N, Bertucci V, Dansereau A et al (2007) A comprehensive approach to the recognition, diagnosis, and severity-based treatment of focal hyperhidrosis: recommendations of the Canadian Hyperhidrosis Advisory Committee. Dermatol Surg 33:908\u2013923","journal-title":"Dermatol Surg"},{"key":"1074_CR28","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jaad.2003.12.040","volume":"51","author":"DR Strutton","year":"2004","unstructured":"Strutton DR, Kowalski JW, Glaser DA, Stang PE (2004) US prevalence of hyperhidrosis and impact on individuals with axillary hyperhidrosis: results from a national survey. J Am Acad Dermatol 51:241\u2013248","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"1074_CR29","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1159\/000051780","volume":"203","author":"J Vadoud-Seyedi","year":"2001","unstructured":"Vadoud-Seyedi J, Heenen M, Simonart T (2001) Treatment of idiopathic palmar\u00a0hyperhidrosis\u00a0with botulinum toxin. Report of 23 cases and review of the literature. Dermatology 203(4):318\u2013321","journal-title":"Dermatology"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-013-1074-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00702-013-1074-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-013-1074-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,24]],"date-time":"2019-07-24T06:59:35Z","timestamp":1563951575000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00702-013-1074-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,20]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["1074"],"URL":"https:\/\/doi.org\/10.1007\/s00702-013-1074-1","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,20]]}}}